Advertisement

Vitamin A, Retinoids and Breast Cancer

  • Richard C. Moon
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 364)

Abstract

Epidemiological investigations have indicated an inverse relationship between vitamin A intake and risk for developing cancer, and over the past several years an extensive effort has been directed towards understanding the mechanism by which vitamin A and retinoids (analogs of vitamin A) inhibit carcinogenesis.1,2

Keywords

Mammary Cancer Mammary Carcinogenesis Mammary Tumorigenesis Retinyl Palmitate Retinyl Acetate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    McCollum, E.V. and M. Davis, The necessity of certain lipids in the diet during growth, J. Biol.Chem. 15:167(1913).Google Scholar
  2. 2.
    Peto, R., R. Doll, J.D. Buckley, and M.B. Sporn, Can dietary beta-carotene materially reduce human cancer rates, Nature290:201 (1981).PubMedCrossRefGoogle Scholar
  3. 3.
    Mori, S., The changes in the paraocular glands which follow the administration of diets low in fat soluble A with notes of the effects of the same diets on the salivary glands and the mucosa of the larynx and trachea, Johns Hopkins Hosp. Bull. 33:357 (1922).Google Scholar
  4. 4.
    Wolbach, S.D. and P.R. Howe, Tissue changes following deprivation of fat soluble vitamin A, J. Exp. Med. 42:753 (1925).PubMedCrossRefGoogle Scholar
  5. 5.
    Harris, C.C., M.B. Sporn, D.G. Kaufman, J.M. Smith, RE. Jackson, and U. Saffiotti, Histo-genesis of squamous metaplasias in the hamster tracheal epithelium caused by vitamin A deficiency or benzo[a]pyrene-ferric oxide, J. Natl. Cancer Inst. 48:743 (1972).PubMedGoogle Scholar
  6. 6.
    Moon, R.C. and L.M. Itri, Retinoids and cancer, in: The Retinoids, M.B. Sporn, D.S. Goodman, and A.B. Roberts, eds., Raven Press, New York (1984).Google Scholar
  7. 7.
    Gullino, P.M., H.M. Pelligrew, and F.H. Grantham, N-Nitrosomethylurea as mammary gland carcinogen in rats, J. Natl. Cancer Inst. 54:401 (1975).PubMedGoogle Scholar
  8. 8.
    McCormick, D.L., C.B. Adamowski, A. Fiks, and R.C. Moon, Lifetime dose-response relationship for mammary tumor induction by a single administration of N-methyl-N nitro-sourea, Cancer Res. 41:1690 (1981).PubMedGoogle Scholar
  9. 9.
    Moon, R.C, D.L. McCormick, and R.G. Mehta, Inhibition of carcinogenesis by retinoids, Cancer Res. (Suppl)43:2469s (1983).Google Scholar
  10. 10.
    Schmahl, D. and M. Habs, Experiments on the influence of an aromatic retinoid on the chemical carcinogenesis in rats by butyl-butanol-nitrosamine and 1,2-dimethylhydrazine, Arzneimittelforschung 28:49 (1978).PubMedGoogle Scholar
  11. 11.
    Moon, R.C., C.J. Grubbs, and M.B. Sporn, Inhibition of 7,12-dimethylbenz[a]anthracene-induced mammary carcinogenesis by retinyl acetate, Cancer Res. 36:2626 (1976).PubMedGoogle Scholar
  12. 12.
    Moon, R.C., R.G. Mehta, and K.V.N. Rao, Retinoids and cancer in experimental animals, in: and D.S. Goodman, eds., Raven Press, New York (1994).Google Scholar
  13. 13.
    Moon, R.C., R.G. Mehta, and D.L. McCormick, Modulation of mammary carcinogenesis by retinoids, in: Vitamins, Nutrition and Cancer, K.N. Prasad, ed., Karger,Basel (1984).Google Scholar
  14. 14.
    Moon, R.C., HJ. Thompson, PJ. Becci, C.J. Grubbs, R.J. Gander, D.L. Newton, J.M. Smith, S.R. Phillips, W.R. Henderson, L.T. Mullen, C.C. Brown, and M.B. Sporn, N-(4-hydroxyphenyl)retinamide, a new retinoid for prevention of breast cancer in the rat, Cancer Res. 39:1339(1979).PubMedGoogle Scholar
  15. 15.
    McCormick, D.L. and R.C. Moon, Influence of delayed administration of retinyl acetate on mammary carcinogenesis, Cancer Res. 42:2639 (1982).PubMedGoogle Scholar
  16. 16.
    Moon, R.C., J.F. Pritchard, R.G. Mehta, C.T. Moides, C.F. Thomas, and N.M. Dinger, Suppression of rat mammary cancer development by N-(4-hydroxyphenyl)retinamide (4-HPR) following surgical removal of first palpable tumor, Carcinogenesis 10:1645 (1989).PubMedCrossRefGoogle Scholar
  17. 17.
    Teelmann, K. and W. Bollag, Therapeutic effect of the arotenoid Ro 15-0778 on chemically induced rat mammary carcinoma, Eur. J. Cancer Clin. Oncol. 24:1205 (1988).PubMedCrossRefGoogle Scholar
  18. 18.
    Dowlatshahi, K., R.G. Mehta, C.F. Thomas, N. Dinger, and R.C. Moon, Therapeutic effect of N(4-hydroxyphenyl)retinamide on N-methyl-N-nitrosourea induced mammary cancer, Cancer Lett. 47:187(1989).PubMedCrossRefGoogle Scholar
  19. 19.
    Maiorana, A. and P. Gullino, Effect of retinyl acetate on the incidence of mammary carcinomas and hepatomas in mice, J. Natl. Cancer Inst. 64:655 (1980).PubMedGoogle Scholar
  20. 20.
    Welsch, C.W., M. Goodrich-Smith, C.C. Brown, and N. Crowe, Enhancement by retinyl acetate of hormone-induced mammary tumorigenesis in female GR/A mice, J. Natl. Cancer Inst. 67:935 (1981).PubMedGoogle Scholar
  21. 21.
    Welsch, C.W, J.V. DeHoog, and R.C. Moon, Inhibition of mammary tumorigenesis in nul-liparous C3H mice by chronic feeding of the synthetic retinoid, N-(4-hydroxyphenyl) retinamide, Carcinogenesis 4:1185 (1983).PubMedCrossRefGoogle Scholar
  22. 22.
    McCormick, D.L., R.G. Mehta, C.A. Thompson, N. Dinger, J.A. Caldwell, and R.C. Moon, Enhanced inhibition of mammary carcinogenesis by combination N-(4-hydroxyphenyl)retinamide and ovariectomy, Cancer Res. 42:509 (1982).Google Scholar
  23. 23.
    Ratko, T.A., C.J. Detrisac, N.M. Dinger, C.T. Thomas, G.J. Kelloff, and R.C. Moon, Chemopreventive efficacy of combined retinoid and tamoxifen treatment following surgical excision of a primary mammary cancer in female rats, Cancer Res. 49:4472 (1989).PubMedGoogle Scholar
  24. 24.
    Ratko, T.A., R.G. Mehta, C.J. Detrisac, G.J. Kelloff, and R.C. Moon, Inhibition of rat mammary gland chemical carcinogenesis by dietary dehydroepiandrosterone or a fluorinated analogue of dehydroepiandrosterone, Cancer Res. 51:481 (1991).PubMedGoogle Scholar
  25. 25.
    Welsch, C.W, C.K. Brown, M. Goodrich-Smith, J. Chiusano, and R.C. Moon, Synergistic effect of chronic prolactin suppression and retinoid treatment in the prophylaxis of N-methyl-N-nitrosourea-induced mammary tumorigenesis in female Sprague-Dawley rats, Cancer Res. 40:3095(1980).PubMedGoogle Scholar
  26. 26.
    Bertram, J.S., Inhibition of neoplastic transformation in vitro by retinoids, Cancer Surv. 3:243 (1983).Google Scholar
  27. 27.
    Thompson, H.J., L.D. Meeker, and P.J. Becci, Effect of combined selenium and retinyl acetate treatment on mammary carcinogenesis, Cancer Res. 41:1413 (1981).PubMedGoogle Scholar
  28. 28.
    Ip, C. and M.M. Ip, Chemoprevention of mammary tumorigenesis by a combined regimen of selenium and vitamin A, Carcinogenesis 2:915 (1981).PubMedCrossRefGoogle Scholar
  29. 29.
    McCormick, D.L., PJ. Becci, and R.C. Moon, Inhibition of mammary and urinary bladder carcinogenesis by a retinoid and a maleic anhydride-divinyl ether copolymer (MVE-2), Carcinogenesis 3:1473 (1982).PubMedCrossRefGoogle Scholar
  30. 30.
    Malone, W.F., G.J. Kelloff, C. Boone, and D.W. Nixon, Chemoprevention and modern cancer prevention, Prev. Med. 18:553 (1989).PubMedCrossRefGoogle Scholar
  31. 31.
    Hong, W.K. and L.M. Itri, Retinoids and human cancer, in: The Retinoids: Biology, Chemistry, and Medicine, 2nd edition, M.B. Sporn, A.B. Roberts, and D.S. Goodman, eds., Raven Press, New York (1994).Google Scholar

Copyright information

© Springer Science+Business Media New York 1994

Authors and Affiliations

  • Richard C. Moon
    • 1
  1. 1.Specialized Cancer CenterUniversity of Illinois at ChicagoChicagoUSA

Personalised recommendations